The role of chronic diseases, environmental and genetic influences on the infection with SARS-CoV-2: boosters, effect modifiers or mediators?

慢性疾病、环境和遗传影响对 SARS-CoV-2 感染的作用:增强剂、效应调节剂还是介质?

基本信息

项目摘要

The recently discovered virus “Severe Acute Respiratory Syndrome CoronaVirus 2” (SARS-CoV-2) is the pathogenic agent of COVID-19. The disease course of COVID-19 is often mild, but leads in a substantial number of cases to hospitalization and even death, which is likely depending on pre-existing conditions and genetic predisposition. Ambient air pollution is a major environmental risk factor for cardio-metabolic, respiratory and neurological diseases, and also has been implicated to significantly contribute to COVID-19 disease spread and severity. It is the objective of COVGENAIR to assess the role of chronic diseases, environmental factors and genetic predisposition and their interplay on the severity of SARS-CoV-2 infections. In particular, we will investigate: (a) the prevalence of SARS-CoV-2 infections and symptoms within different age and risk groups, (b) disentangle the association between environmental exposures and SARS-CoV-2 infections, (c) identify susceptible subgroups in the population who might be particularly vulnerable for an infection with the SARS-CoV-2 virus, and (d) investigate the long-term health effects of an infection with SARS-CoV-2. This proposal is based on data obtained from three comprehensively phenotyped longitudinal cohort studies, all reaching back more than 20 years with participants now being 20 to 95 years old, comprising an extensive assessment of previous subclinical disease manifestations, exposure history, lifestyle factors and genotyping before the COVID-19 pandemic. Within the proposal, we will collect data on SARS-CoV-2 infections by questionnaire and antibody tests and invite subjects for re-examination to assess the most common consequences of COVID-19, such as loss of smell and persistent respiratory problems. Elucidating the environmental and molecular pathways which could increase the risk of a SARS-CoV-2 infection to identify susceptible subjects and determining the long-term post-COVID-19 health outcomes on the respiratory, cardiometabolic and neurological system are important steps in managing the public health challenges of the COVID-19 pandemic. Specifically, understanding the influence of our genetic make-up and the interplay with air pollution and pre-existing conditions on the response to an infection in different age groups would help to better understand the underlying molecular pathways as well as the variability and pathogenesis in at-risk individuals.
最近发现的病毒“严重急性呼吸道综合征冠状病毒2”(SARS-CoV-2)是COVID-19的病原体。COVID-19的病程通常较轻,但会导致大量病例住院甚至死亡,这可能取决于先前存在的疾病和遗传易感性。环境空气污染是心脏代谢、呼吸系统和神经系统疾病的主要环境风险因素,也被认为是COVID-19疾病传播和严重程度的重要因素。COVGENAIR的目的是评估慢性疾病、环境因素和遗传易感性的作用及其对SARS-CoV-2感染严重程度的相互作用。特别是,我们将调查:(a)SARS-CoV-2感染和症状在不同年龄和风险群体中的流行率,(B)解开环境暴露与SARS-CoV-2感染之间的联系,(c)确定人群中可能特别容易感染SARS-CoV-2病毒的易感亚群,以及(d)调查SARS-CoV-2感染对健康的长期影响。该提案基于三项全面表型纵向队列研究获得的数据,所有研究均追溯到20多年前,参与者现在年龄在20至95岁之间,包括对COVID-19大流行前既往亚临床疾病表现、暴露史、生活方式因素和基因分型的广泛评估。在该提案中,我们将通过问卷和抗体测试收集SARS-CoV-2感染的数据,并邀请受试者进行重新检查,以评估COVID-19最常见的后果,例如嗅觉丧失和持续的呼吸问题。阐明可能增加SARS-CoV-2感染风险的环境和分子途径,以识别易感受试者,并确定COVID-19对呼吸系统、心脏代谢和神经系统的长期后健康结果,是应对COVID-19大流行的公共卫生挑战的重要步骤。具体而言,了解我们的遗传组成的影响以及与空气污染和预先存在的条件对不同年龄组感染反应的相互作用将有助于更好地了解潜在的分子途径以及风险个体的变异性和发病机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professorin Dr. Annette Peters其他文献

Professorin Dr. Annette Peters的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professorin Dr. Annette Peters', 18)}}的其他基金

Short-term Health Effects of Fine and Ultra-fine Particle Pollution in Beijing, China
中国北京细颗粒物和超细颗粒物污染的短期健康影响
  • 批准号:
    5429692
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

黏液层/细菌被膜双重渗透型抗菌聚多肽纳米载体用于肺部给药治疗慢性阻塞性肺病
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
  • 批准号:
    82370889
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
弓状核介导慢性疼痛引起动机下降的神经环路机制及rTMS干预研究
  • 批准号:
    82371536
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
星形胶质细胞介导的髓鞘吞噬参与慢性脑低灌注白质损伤的机制研究
  • 批准号:
    82371307
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
钙激活的大电流钾离子通道β1亚基影响慢性肾脏病进展的机制探讨
  • 批准号:
    81070587
  • 批准年份:
    2010
  • 资助金额:
    38.0 万元
  • 项目类别:
    面上项目
Jagged2high CD11bhigh 调节性树突状细胞防治cGVHD的实验研究
  • 批准号:
    30972790
  • 批准年份:
    2009
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Modulation of the biliary immune niche by the microbiome
微生物组对胆道免疫生态位的调节
  • 批准号:
    10349405
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Decoding the functional pleiotropy of IL-20Rβ ligands in inflammation and tumorigenesis
解码 IL-20Rβ 配体在炎症和肿瘤发生中的功能多效性
  • 批准号:
    10350447
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
  • 批准号:
    10696442
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role of STING in Cholestatic Liver Injury
STING 在胆汁淤积性肝损伤中的作用
  • 批准号:
    10637131
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role of skeletal muscle IPMK in nutrient metabolism and exercise
骨骼肌IPMK在营养代谢和运动中的作用
  • 批准号:
    10639073
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
  • 批准号:
    10642598
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli
产肠毒素和致病性大肠杆菌介导的腹泻和肠道炎症的机制
  • 批准号:
    10674072
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了